Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Christine Sethna |
Contact phone | 718-470-3423 |
Contact email | csethna@nshs.edu |
Dua signed dt | June 17, 2010, midnight |
PI name | Christine Sethna, Howard Trachtman |
Site approved dt | Feb. 4, 2010, midnight |
Niddk signed dt | July 14, 2010, midnight |